Jun Yong Choi Selected Research

Cross Infection (Nosocomial Infection)

3/2018	Increasing Incidence of Listeriosis and Infection-associated Clinical Outcomes.
1/2018	Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
3/2016	Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital.
2/2014	Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
7/2012	Delta neutrophil index: could it predict mortality in patients with bacteraemia?
1/2008	Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Yong Choi Research Topics

Disease

32	Infections 01/2024 - 12/2005
21	COVID-19 05/2024 - 06/2020
21	Sepsis (Septicemia) 10/2023 - 01/2008
17	Bacteremia 04/2023 - 08/2005
14	HIV Infections (HIV Infection) 07/2023 - 03/2004
12	Acquired Immunodeficiency Syndrome (AIDS) 10/2022 - 03/2004
11	Neoplasms (Cancer) 04/2024 - 12/2005
9	Pneumonia (Pneumonitis) 02/2024 - 12/2011
9	Septic Shock (Toxic Shock Syndrome) 10/2021 - 12/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 12/2005
6	Tuberculosis (Tuberculoses) 01/2023 - 05/2011
6	Cross Infection (Nosocomial Infection) 03/2018 - 01/2008
5	Inflammation (Inflammations) 07/2023 - 11/2012
5	Coinfection 01/2023 - 03/2013
5	Diabetes Mellitus 09/2022 - 12/2005
4	Breakthrough Infections 05/2024 - 10/2022
4	Chronic Renal Insufficiency 12/2023 - 02/2009
4	Human Influenza (Influenza) 08/2023 - 01/2012
4	Bacterial Infections (Bacterial Infection) 01/2019 - 12/2006
3	Obesity 04/2024 - 11/2009
3	Endocarditis 01/2023 - 08/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 08/2016
3	Fungemia 01/2023 - 09/2009
3	Aspergillosis 01/2023 - 08/2012
3	Hepatitis B 10/2022 - 03/2013
3	Renal Insufficiency (Renal Failure) 09/2022 - 09/2009
3	Dyslipidemias (Dyslipidemia) 09/2022 - 11/2009
3	Urinary Tract Infections (Urinary Tract Infection) 12/2020 - 01/2014
3	Hepatitis C 01/2016 - 01/2014
3	Carotid Artery Diseases 05/2015 - 12/2011
2	Stroke (Strokes) 07/2023 - 12/2014
2	Coronary Disease (Coronary Heart Disease) 07/2023 - 09/2022
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2017
2	Candidemia 01/2023 - 06/2019
2	Lymphadenopathy 01/2023 - 03/2017
2	Fibrosis (Cirrhosis) 11/2022 - 04/2016
2	Liver Diseases (Liver Disease) 11/2022 - 12/2017
2	Heart Failure 06/2022 - 06/2019
2	Critical Illness (Critically Ill) 01/2022 - 06/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2012
2	Gram-Positive Bacterial Infections 10/2021 - 04/2016
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2021 - 04/2020
2	Community-Acquired Infections 08/2020 - 12/2019

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 12/2005
16	VaccinesIBA 05/2024 - 07/2011
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2012
7	Tenofovir (Viread)FDA Link 01/2023 - 01/2014
6	Messenger RNA (mRNA)IBA 05/2024 - 11/2021
6	BNT162 VaccineIBA 05/2024 - 01/2022
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2009
6	C-Reactive ProteinIBA 05/2020 - 12/2013
5	Carbapenems (Carbapenem Antibiotics)IBA 03/2024 - 12/2005
4	EnzymesIBA 10/2023 - 11/2012
3	ChAdOx1 nCoV-19IBA 02/2024 - 01/2023
3	COVID-19 VaccinesIBA 02/2024 - 11/2021
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2012
3	carbapenemaseIBA 04/2023 - 03/2016
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2023 - 01/2012
3	Neutralizing AntibodiesIBA 01/2023 - 01/2022
3	Anti-HIV Agents (AIDS Drugs)IBA 09/2022 - 03/2004
3	Reverse Transcriptase InhibitorsIBA 09/2022 - 03/2004
3	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2009
3	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 07/2011
3	QuinolonesIBA 08/2019 - 12/2005
3	Lactic Acid (Lactate)FDA LinkGeneric 06/2019 - 12/2013
2	2019-nCoV Vaccine mRNA-1273IBA 02/2024 - 07/2023
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2024 - 10/2022
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024 - 10/2022
2	CoagulaseIBA 01/2024 - 06/2022
2	AntibodiesIBA 10/2023 - 01/2009
2	ImmunosorbentsIBA 10/2023 - 11/2012
2	Immunoglobulin G (IgG)IBA 10/2023 - 01/2023
2	PTX3 proteinIBA 07/2023 - 03/2017
2	AzolesIBA 01/2023 - 08/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 08/2007
2	EchinocandinsIBA 01/2023 - 06/2019
2	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 09/2009
2	Alanine Transaminase (SGPT)IBA 11/2022 - 01/2016
2	CytokinesIBA 10/2022 - 05/2015
2	NucleosidesIBA 09/2022 - 03/2004
2	Vancomycin FDA LinkGeneric 12/2021 - 10/2021
2	Matrix Metalloproteinase 13IBA 01/2021 - 11/2014
2	SteroidsIBA 12/2020 - 12/2005
2	beta-LactamsIBA 08/2020 - 12/2005
2	GlycopeptidesIBA 05/2020 - 01/2018

Therapy/Procedure

34	Therapeutics 12/2022 - 08/2005
11	Art Therapy 08/2023 - 01/2014
10	Highly Active Antiretroviral Therapy (HAART) 07/2023 - 04/2006
5	Length of Stay 05/2021 - 12/2005
4	Catheters 01/2022 - 02/2009
4	Central Venous Catheters 05/2020 - 01/2010
4	Resuscitation 03/2017 - 06/2012
4	Early Goal-Directed Therapy 03/2017 - 06/2012
3	Hand Hygiene 03/2024 - 05/2013
3	Personal Protective Equipment 03/2024 - 12/2015
2	Critical Care (Surgical Intensive Care) 03/2023 - 09/2016
2	Traditional Medicine (Folk Remedies) 01/2023 - 06/2020
2	Urinary Catheters 01/2023 - 03/2015
2	Renal Dialysis (Hemodialysis) 01/2022 - 11/2011